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Abstract- This work has demonstrated the functionalization of
an amphiphilic diblock copolymer, comprised of polyethylene
oxide-polymethyl methacrylate (PEO-PMMA), as well as a
triblock copolymer comprised of polymethyloxazoline-
polydimethylsiloxane-polymethyloxazoline(PMOXA-PDMS-PM
OXA) with the dexamethasone (Dex) glucocorticoid
anti-inflammatory. Interfacial deposition of the copolymer and
the Dex molecules and subsequent transfer of the hybrid materials
to solid substrates were characterized to evaluate the potential of
utilizing this composite material as a suppressor of
cyto-inflammation to enhance implant biocompatibility. Given the
extremely thin dimensions of the film (-4nm), this material would
have negligible impact upon the size of the coated device to
preclude biological stress. The composite films were interfaced
with the RAW264.7 murine macrophages which served as a model
cell line for the evaluation of Nuclear factor-kappaB
(NF-icB)-induced production of a host of inflammatory cytokines
including interleukin-6, interleukin-12, tumor necrosis
factor-alpha (TNFa), as well as the inducible Nitric Oxide
Synthase signaling factor which is known to be involved with
stress-related processes such as neuronal damage.
Lipopolysaccharide or LPS is a component of bacterial
membranes that elicits cellular stress following application to
RAW cell cultures. Following the induced stress response,
significant reductions in the expression of genes associated with
the aforementioned cytokines and signaling molecules indicated
that macrophages in direct contact with the functionalized
copolymer were able to collect Dex that was released from within
the polymer network to attenuate cyto-inflammation mechanisms.
This composite membrane represents a medically-relevant
technology to promote chronic implant functionality and
preclusion of bio-fouling.
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I. INTRODUCTION
Block copolymers have been shown to be effective matrices
to support protein function for the mimicry of key natural
biological processes such as energy conversion, as well as
voltage-gated ion transport [1-9]. While conventional
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lipid-based systems have enabled single protein
characterization and mechanisms of functionality to be
elucidated [10-13], block copolymers represent a highly
versatile approach towards tailored biology, whereby specific
properties can be engineered into the material to accommodate
specific protein geometries, desired block lengths,
compositions, and charge properties, to name a few. In
addition, the addition of endgroups, such as acrylate, can be
made to enable UV, or chemically-induced polymeric
crosslinking to enhance material stability for enhanced device
robustness.
Block copolymers, such as the PEO-PMMA and
PMOXA-PDMS-PMOXA materials that were utilized for this
study can also possess the amphiphilic properties (polymer
structure has alternating hydrophilic and hydrophobic
properties) that enable material integration at the air-water
interface and subsequent deposition onto solid substrates via
the Langmuir-Blodgett modality. More specifically, this
technique can be used to deposit large area, uniform thin films
to coat solid state devices, such as those used for implants.
Deposition of the amphiphilic molecules is carried out by
adding the polymer to a subphase of water, and due to the
alternating hydrophobic-hydrophilic nature of the amphiphile,
polymeric solubilization into the subphase is then precluded.
Compression of the interfacial material then enables stable
film formation.
We have demonstrated the deposition of the PEO-PMMA
and PMOXA-PDMS-PMOXA copolymers at the air-water
interface followed by the lacing ofthe copolymers with the Dex
anti-inflammatory for subsequent composite film transfer to the
substrate. RAW264.7 culture atop these functionalized
substrates revealed substantially decreased LPS-induced
cellular inflammation which was indicative of
polymer-mediated transfer of Dex across the cell membrane to
suppress NF-KB-induced stress response. Langmuir isotherms
were utilized to confirm the maintenance of the hydrophilic
Dex at the air-water interface while quantitative real time
Polymerase Chain Reaction (RT-PCR) was utilized to assess
gene program attenuation by quantifying inflammatory gene
mRNA expression (Fig. 1).
II. MATERIALS AND METHODS
A. Polymer Preparation and Characterization
The PMOXA-PDMS-PMOXA and PEO-PMMA
copolymers were solubilized to 0.1mg/ml in chloroform and
stirred overnight to result in a translucent, homogeneous
solution for LB deposition. We have previously characterized
the thickness of the materials, using the
PMOXA-PDMS-PMOXA structure as an example, by
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Figure 1. Dex is known to interfere with p65 interaction with transcriptional machinery (e.g. P-TEFb) or coactivators to suppress inflammation.
performing a secondary treatment of the
chloroform-solubilized copolymer with toluene and suspending
a droplet across a 25ptm-thick hydrophobic septum flanked by 2
Ag/AgCl electrodes for capacitance measurements as given by:
C=c&c1Ald, where C is the membrane capacitance, co is the
permittivity of free space (=8.9 x 10- 19 F/m), el is the relative
dielectric constant of the PDMS hydrophobic block, A is the
measured area ofthe annulus in the septum (=250,m), and d is
the thickness of the membrane. The resultant thickness of the
materials were determined to range between 3-4nm [14-1 8].
B. General Langmuir-Blodgett Film Fabrication Protocol for
Polymeric Substrates
LB films were fabricated using a KSV 2000 Standard
Langmuir Trough with a Teflon® base and a subphase ofwater.
To preclude sample contamination from ambient particles, the
entire trough was covered with a plastic case and a small door
was integrated to allow for manual manipulation/cleaning of
the trough. The base was cleaned with chloroform using a
cotton swab and large tweezers and then rinsed thoroughly with
nanopure water. The water was then swept using cotton swabs
into the central reservoir ofthe trough and suctioned offusing a
vacuum pump. This step was performed three times to ensure
trough cleanliness. The trough was then filled with nanopure
water while paying careful attention not to deposit water
droplets along the edge of the trough. The Wilhemy platinum
pressure sensing plate (stored in MeOH was then thoroughly
rinsed using nanopure water, and subsequently sterilized using
a torch. The pressure sensor was then zeroed and the ready for
film deposition (Fig. 2).
C. Glucocorticoid Preparation/Deposition for Inflammation
Attenuation Studies
Water soluble dexamethasone (Sigma-Aldrich, Inc.) was
dissolved in nanopure water to a concentration of lmg/ml. The
drug was then added to an interfacial pre-formed lOmN/m
copolymer film and changes in surface pressure were
monitored to confirm dexamethasone presence at the air-water
interface. After 30 minutes of allowing the film to reach
equilibrium, compressions were performed at a rate of
1mm/min to a maximum pressure of 3OmN/m for LB
deposition onto glass slides (25mmx75mm) at a rate of
1mm/min (Fig. 3). (VWR Scientific, Inc.) (Films were
compressed to >5OmN/m until collapse for Langmuir film
characterization of film properties). The slides were then used
for RAW264.7 murine macrophage culture and quantitative
Polymerase Chain Reaction (RT-PCR) analysis.
RAW264.7 (ATCC) cells were cultured at 37°C in DMEM
supplemented with 10% FBS and 5% Penicillin/Streptomycin.
Following the acquisition of cultures of adequate density, cells
cultured on bare glass as well as the composite films were
exposed to lipopolysaccharide (LPS) for 4 hours, and slides
were subsequently transferred to new Petri dishes and lml of
TRIzol cell lysis solution was added to wash the slides and
collect the genetic material. RNA isolation was done according
to the manufacturer's protocol. Subsequent conversion of the
RNA to cDNA was performed using the I-script enzyme
(Bio-Rad) [19-21].
Following conversion of the isolated mRNA to cDNA,
RT-PCR analysis (Bio-Rad, Richmond, CA, USA) was
performed to examine the expression of tumor necrosis
factor-alpha (TNFo, IP-10, Il-6, and Il-12) primers available
upon request) following LPS induction both with and without
dexamethasone activity.
III. RESULTS AND DISCUSSION
Dexamethasone (Dex) deposition was conducted atop both
the PEO-PMMA copolymer and PMOXA-PDMS-PMOXA
copolymer structures. Dex presence was confirmed via the
application of a FITC-Dex compound atop the pre-formed
copolymer monolayer (Fig. 4). FITC-Dex added without the
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Figure 2. The process for copolymer-mediated Langmuir-Blodgett deposition is shown here. 1) The copolymer was deposited at the air-water interface to a
starting pressure of 10-15mN/m. 2) The functional molecule (e.g. Dex) was added to the surface ofthe pre-formed membrane in a dropwise fashion to minimize
copolymer film perturbation. 3) The film was compressed at a rate of 1mm/min to fabricate a uniform, tightly packed composite material that could be tethered to
the substrate via the copolymer. 4) The deposition process onto the substrate was carried out at a rate of 1 mm/min to ensure complete film formation.
copolymer resulted in the inability to transfer the
anti-inflammatory to solid substrates following film
compression. Compression isotherms for Dex-only depositions
at the air-water interface resulted in the inability to generate a
steadily increasing surface pressure isotherm. In fact, the
compression isotherm resembled what would commonly be
observed if no amphiphile were present at the air-water
interface (Data not shown).
Following confirmation of Dex-copolymer composite film
fabrication, RAW264.7 cells were cultured atop the active
substrates as well as bare glass slides and LPS was utilized to
induce cellular stress and the production of a suite of
inflammatory cytokines and signaling molecules. LPS binds to
the membrane-bound Toll-like receptor 4 (TLR4) that
simulates bacterial infection and elicits the activation of
transcriptional factors (e.g. Nuclear Factor kappa B (NFKB))
for inflammatory cytokine production. For the purposes of this
study, TNFo was
selected as the cytokine marker for macrophage stress, and
RT-PCR was utilized to examine the expression of TNFo
mRNA (Fig. 5). Macrophages activated by LPS that were
cultured atop bare substrates resulted in significantly higher
levels ofinflammation over samples where LPS was introduced
to macrophages that were cultured atop either 3, or 7 layers of
Dex-copolymer composites. This outcome demonstrated that
the drug-dosing capabilities of the hybrid material could be
tailored based upon the number of layers deposited. Because
the copolymer membrane dimensions are within the range of
2nm (diblock)-4nm (triblock) in thickness, coating substrates
(e.g. implants) with multiple layers would result in minimal
impact upon overall device dimensions. In addition, on
samples where solutions of Dex were incubated directly with
the glass culture slides/self-assembled without the polymer,
LPS treatment of cultured macrophages resulted in the absence
of inflammatory suppression that was previously observed with
samples cultured atop the Dex/copolymer composites (Fig. 6).
As such, this study showed that 1) Interfacially deposited Dex
atop the polymeric amphiphiles could be dispensed to
macrophages cultured on the active composite, and 2)
Self-assembled Dex without the copolymer substrate was
unable to stay tethered to the glass slide for subsequent transfer
to the macrophages (Fig. 7).
As demonstrated by the RT-PCR trials, the copolymer served
as both a buoying element at the air-water interface for the
deposition ofDex, as well as a tethering component to maintain
the integrity between the Dex and the glass substrate. This was
an expected observation as the nature of the
Figure 3. Water-soluble Dex deposited atop the copolymer was suspended at
the surface of the Langmuir trough and integrated with the copolymer
(circle) while Dex was shown to submerse into the subphase when deposited
without the copolymer (square).
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Figure 4. (Top) Dex deposited atop the polymer thin film was shown to be
integrated and transferred with the copolymer to the solid substrate for
cellular interfacing. (Inset) Dex deposited atop the water was shown using
both the isotherm and fluorescence microscopy to submerse into the
subphase, precluding transfer onto the substrate.
inhibit NF-kB target genes through the binding of p65 and
blocking of p65 recruited transcriptional machinery, such as
P-TEFb [22].
With respects to assessing the chronicity of material
functionality, continued work will address the replenishing of
Dex stores within the planar copolymers that have run out of
the corticosteroid. This may be potentially accomplished using
vesicular targeting strategies. More specifically, due to the
ability to functionalize the surface of copolymer vesicles that
are enclosing Dex, planar films that are situated on solid
substrates may be interfaced with injectable vesicles for
targeted interactions to restore the corticosteroid supplies.
This study has demonstrated the concept of applying
copolymer amphiphiles as the foundational element of
fabricating thin films with versatile functionalities. Using
stress-suppression as an exemplary case, we have shown that
the copolymer element enabled functional material (Dex)
deposition, and played a secondary role as an anti-protein
adsorption and tethering component. As such, this
methodology represents a broadly applicable technique for life
science studies as well as potential medical applications.
copolymer-substrate interaction, believed to be based upon a
high density Van der Waals interaction, was previously
demonstrated. As such, the intercalation of the Dex molecules
within these strongly attached PMOXA-PDMS-PMOXA and
PEO-PMMA copolymers was expected to be maintained, and
potentially enhanced following endgroup crosslinking via UV
exposure. This method of treatment to enhance material
robustness may not be amenable towards more conventional,
lipid-based amphiphiles that are less robust than the copolymer
molecules as UV violet wavelengths may irreversibly damage
lipid molecule structure. Suppression of LPS-mediated
induction ofTNFo in RAW264.7 cells demonstrated the ability
of these copolymers in suppressing immune response through
Dex activation of the glucocorticoid receptor, GR, which
results in GR binding and inhibition NF-kB subunit, p65. The
activation ofGR by Dex has been previously shown to robustly
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Figure 5. RT-PCR examination TNF, IP-0, 11-6, and 11-12 mRNA show
major reductions in inflammation based on the number of DEX- films
deposited. These films may be useful towards eliminating initial onset of
cellular inflammation that may trigger device fouling.
IV. CONCLUSION
We have demonstrated the fabrication of a robust,
copolymer-based therapeutic material for the suppression of
cellular stress/inflammation. Following the deposition of single
molecule thick copolymer Langmuir films, the copolymers
were functionalized with Dex, a corticosteroid known to
attenuate NF-KB mediated inflammatory response. Following
the interfacing of RAW264.7 murine macrophages with the
hybrid therapeutic material, RT-PCR was performed to
examine cytokine release from the macrophages. Results
showed significant decreases in inflammation using a spectrum
of signaling molecules as read-outs, including gene expression
levels of 11-6, 11-12, TNFu, IP-10, and iNOS. As it has
previously been shown that iNOS expression can be correlated
with cellular injury (e.g. neurons), our results show that this
nanoscale composite film of 4nm thickness represents a
non-invasive approach to coating various surfaces/substrates
that may reside at an in vitro or in vivo interface. This may
include the coating of implants to facilitate chronic device
functionality as well as preclusion of bio-fouling. These
coatings may also be useful for single-cell studies to examine
polymeric activation of cellular gene expression pathways for
biotic-abiotic interfacing studies (e.g. mechano-sensation,
metabolism, etc.). Furthermore, given the versatility of this
technology, the polymers may also be assembled into vesicular
structures that can serve as reservoirs for therapeutic molecules.
Further engineering of the surface functionalization groups of
these vesicles will enable intelligent delivery of drugs to
specific areas, such as previously coated planar thin films that
require drug replenishment, or the ability to target and facilitate
on-demand vesicular endocytosis to prevent excessive dosing.
As such, the fruition of these materials as well as the potent
performance of these composites is expected to serve as a
modality for novel medical capabilities, as well as a platform
for fundamental cellular studies.
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Figure 6. Dex-functionalized films show an early complete suppression of
TNF production from RAW cells.
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Figure 7. For samples where Dex was self-assembled onto the glass
substrate without the polymer, it could be seen that stress attenuation was
precluded. This showed that the copolymer enabled both interfacial Dex
deposition as well as the ability to tether the Dex to the substrate and sustain
the interface between the macrophages and anti-inflammation capabilities
ofthe composite material.
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